Barclays has initiated coverage on AMETEK Inc (AME) with an Equal-Weight rating as of September 9, 2025. This marks the firm's first assessment of the company, which specializes in manufacturing electronic instruments and electromechanical devices. Headquartered in Berwyn, Pennsylvania, AMETEK employs 21,500 people and operates through two segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG).
The EIG segment designs advanced analytical and measurement instruments for various markets including aerospace, medical, and industrial. Meanwhile, the EMG segment focuses on engineered medical components and automation solutions.
As of now, AMETEK's stock is priced at $192.89, with a market capitalization of $43.8 billion. The company boasts a P/E ratio of 29.79 and an EPS of 6.34, alongside a dividend yield of 64.7%. Upcoming earnings are expected on July 29, 2026, with an EPS estimate of $1.97 and revenue projected at $2.0 billion.
Analyst ratings, such as this one from Barclays, provide insights based on research and financial models. However, they should be viewed as one of many factors to consider when making investment decisions. Analyst opinions can evolve over time as new information emerges, and different analysts may have varying perspectives on the same company.